Cargando…
Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study
INTRODUCTION: Atopic dermatitis (AD) is a chronic disease that occurs mainly in children. Topical corticosteroids are the main treatment for mild to moderate AD, although they can induce side effects. The efficacy and tolerability of xyloglucan and pea protein (XG-PP) was compared with hydrocortison...
Autores principales: | Sowlati, Mehdi, Morariu, Silviu-Horia, Orzan, Olguta, Veraldi, Stefano, Dodiuk-Gad, Roni P., Orasan, Remus I., Gainaru, Cristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613178/ https://www.ncbi.nlm.nih.gov/pubmed/37740857 http://dx.doi.org/10.1007/s13555-023-01035-6 |
Ejemplares similares
-
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis
por: Campolo, Michela, et al.
Publicado: (2020) -
SNG100, a novel topical treatment for moderate atopic dermatitis, in patients aged 6 years or older: A randomised, double‐blind, active‐controlled trial
por: Samuelov, Liat, et al.
Publicado: (2023) -
Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009) -
Topical steroid addiction in atopic dermatitis
por: Fukaya, Mototsugu, et al.
Publicado: (2014) -
Topical Therapy in Atopic Dermatitis in Children
por: Sathishkumar, Dharshini, et al.
Publicado: (2016)